Ke Li
Corporate Officer/Principal bij Shenyang Sunshine Pharmaceuticals Co., Ltd.
Profiel
Ke Li is a professional who has worked as a Vice President at Shenyang Sunshine Pharmaceuticals Co., Ltd.
since 1993.
Prior to this, Mr. Li worked as a Vice President at 3SBio, Inc. Mr. Li received an undergraduate degree from Jilin University in 1988 and another undergraduate degree from Liaoning University in 2001.
Actieve functies van Ke Li
| Bedrijven | Functie | Begin |
|---|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 01-03-1993 |
Eerdere bekende functies van Ke Li
| Bedrijven | Functie | Einde |
|---|---|---|
| 3SBIO INC. | Corporate Officer/Principal | - |
Opleiding van Ke Li
| Jilin University | Undergraduate Degree |
| Liaoning University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
